Loading…
Lobbying Income
$100K
Filings
22
Unique Clients
2
Active Period
2019–2025
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.
2025 · first_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
Supported HR 1463 a bill that restricts funding for FDA's LDT ruling
Client expense: — · Firm income: $9,000
Matched citations: HR 1463
Saving Access to Laboratory Services Act
2024 · fourth_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377 Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · third_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377 Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · second_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377 Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · first_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · first_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: —
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2023 · fourth_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2023 · fourth_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: —
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2023 · third_quarter · Client: CHIPPS, CAFFREY AND DUBILIER, P. S. C.
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: —
Matched citations: HR 2377
Source: Senate LDA